Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Treatment by BCG”

122 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 122 results

Not applicableNot Yet RecruitingNCT07724886
What this trial is testing

Role of ERBT Plus Intravesical BCG in Intermediate-Risk or High-Risk NMBC

Who this might be right for
Bladder Cancer
Chinese University of Hong Kong 732
Large-scale testing (Phase 3)UnknownNCT02948543
What this trial is testing

Adding Mitomycin to BCG as Adjuvant Intravesical Therapy for High-risk Non-Muscle-invasive Bladder Cancer

Who this might be right for
Bladder Cancer
University of Sydney 501
Testing effectiveness (Phase 2)Study completedNCT04496219
What this trial is testing

Acupuncture for the Treatment of Intravesical BCG-Related Adverse Events in High-Risk Non-muscle Invasive Bladder Cancer

Who this might be right for
Bladder Urothelial Carcinoma In SituRecurrent Bladder Urothelial CarcinomaStage 0a Bladder Cancer AJCC v8+3 more
Fred Hutchinson Cancer Center 45
Large-scale testing (Phase 3)Study completedNCT00427570
What this trial is testing

Fluorouracil, Semustine, and Vincristine Compared With BCG in Treating Patients With Dukes' B or Dukes' C Colon Cancer That Has Been Removed By Surgery

Who this might be right for
Colorectal Cancer
NSABP Foundation Inc
Testing effectiveness (Phase 2)Looking for participantsNCT06388720
What this trial is testing

The Clinical Effectiveness and Safety of Intravesical Mitomycin-C and Gemcitabine Sequential Therapy

Who this might be right for
Bladder Cancer
National Cancer Center, Korea 82
Early research (Phase 1)Study completedNCT02808143
What this trial is testing

Pembrolizumab and BCG Solution in Treating Patients With Recurrent Non-Muscle-Invasive Bladder Cancer

Who this might be right for
Recurrent Bladder CarcinomaStage 0a Bladder Urothelial CarcinomaStage 0is Bladder Urothelial Carcinoma+1 more
Northwestern University 9
Large-scale testing (Phase 3)Ended earlyNCT00384891
What this trial is testing

Hyperthermia Treatment in Conjunction With Mitomycin C Versus Bacillus Calmette-Guérin Immunotherapy (BCG) for Superficial Bladder Cancer

Who this might be right for
Urinary Bladder DiseasesUrinary Bladder NeoplasmsUrinary Bladder Cancer+5 more
Medical Enterprises Europe B.V. 190
Testing effectiveness (Phase 2)Active Not RecruitingNCT06187506
What this trial is testing

Disitamab Vedotin Combined With BCG Therapy in HER2-expressing High-risk Non-muscle Invasive Bladder Cancer

Who this might be right for
Non-muscle Invasive Bladder CancerHER-2 Protein Overexpression
Fudan University 20
Testing effectiveness (Phase 2)Looking for participantsNCT07307456
What this trial is testing

Toripalimab Combined With BCG Perfusion for the Treatment of HR-NMIBC After TURBT Surgery Exploration

Who this might be right for
Bladder Cancer
Changhai Hospital 31
Not applicableUnknownNCT06374914
What this trial is testing

Sequential Intravesical Gemcitabine and Docetaxel for Rescue Therapy in BCG Unresponsive Non-muscle Invasive Bladder Cancer Patients

Who this might be right for
Bladder CancerBCGGemcitabine+2 more
Dokuz Eylul University 120
Not applicableUnknownNCT02895620
What this trial is testing

Effect on Xpert® Bladder Test of Urines Inflammatory Milieu Induced by BCG Treatment of Patients With NMIBC

Who this might be right for
Non Muscle Invasive Bladder CancerTreatment by BCG
Institut Claudius Regaud 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT05644041
What this trial is testing

Intravesical Gem/Doce in Patients With NMIBC

Who this might be right for
Urinary Bladder Cancer
University of Arizona 31
Early research (Phase 1)UnknownNCT06427291
What this trial is testing

Clinical Study of T3011 Intravesical Instillation for Treatment of NMIBC Patients

Who this might be right for
Bladder Cancer
Fudan University 20
Large-scale testing (Phase 3)Study completedNCT01316874
What this trial is testing

Intravesical AD 32 (Valrubicin) in Patients With Carcinoma in Situ (CIS) of the Bladder Who Have Failed or Have Recurrence Following Treatment With Bacillus Calmette-guerin (BCG)

Who this might be right for
Carcinoma in SituBladder Cancer
Endo USA Inc., a Keenova Therapeutics Company 90
Testing effectiveness (Phase 2)Study completedNCT00004122
What this trial is testing

BCG Plus Interferon Alfa 2b in Treating Patients With Bladder Cancer

Who this might be right for
Bladder Cancer
Roswell Park Cancer Institute
Testing effectiveness (Phase 2)Looking for participantsNCT03945162
What this trial is testing

Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients

Who this might be right for
Non-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCG
Theralase® Technologies Inc. 90
Large-scale testing (Phase 3)Active Not RecruitingNCT06462001
What this trial is testing

BCG + MMC: Adding Mitomycin C to BCG in High-risk, Non-muscle-invasive Bladder Cancer

Who this might be right for
Transitional Cell CarcinomaTransurethral Resection
Nottingham University Hospitals NHS Trust 500
Large-scale testing (Phase 3)Study completedNCT00003279
What this trial is testing

Vaccination Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer

Who this might be right for
Lung Cancer
European Organisation for Research and Treatment of Cancer - EORTC 500
Large-scale testing (Phase 3)UnknownNCT00052130
What this trial is testing

Vaccine Therapy for Patients With Stage III Melanoma

Who this might be right for
Malignant Melanoma
CancerVax Corporation 1,118
Not applicableStudy completedNCT07798479
What this trial is testing

Age and Bladder Cancer Outcomes After BCG Treatment: A Multicenter Study

Who this might be right for
Bladder CancerNMIBC
Insel Gruppe AG, University Hospital Bern 64
Next Page